Biogen is accused of causing submissions of false claims to Medicare and Medicaid by paying physicians kickbacks to prescribe its multiple sclerosis drugs Avonex, Tysabri and Tecfidera.
/PRNewswire/ Setting a new standard for whistleblower awards, the United States, state governments and Greene LLP client Michael Bawduniak have agreed to.
A Biogen Inc. whistle-blower will collect almost $250 million for bringing to light a kickback scheme the company agreed to resolve by paying the US and
The Massachusetts-based firm - which made $1bn profit last year - was charged with giving medics lavish meals, speaking fees, and sham consulting deals in for doling out the drugs.